Compile Data Set for Download or QSAR
Report error Found 294 Enz. Inhib. hit(s) with all data for entry = 12435
TargetTyrosine-protein kinase BTK [C481S](Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702637(US20240360154, Compound Z197)
Affinity DataIC50: 1.30nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [C481S](Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702561(US20240360154, Compound Z120)
Affinity DataIC50: 2nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702637(US20240360154, Compound Z197)
Affinity DataIC50: 3nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [C481S](Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702547(US20240360154, Compound Z24-c)
Affinity DataIC50: 3nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [C481S](Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702548(US20240360154, Compound Z24-d)
Affinity DataIC50: 3.10nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [C481S](Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702630(US20240360154, Compound Z79)
Affinity DataIC50: 3.20nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702547(US20240360154, Compound Z24-c)
Affinity DataIC50: 3.20nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [C481S](Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702584(US20240360154, Compound Z41-2a)
Affinity DataIC50: 3.40nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702548(US20240360154, Compound Z24-d)
Affinity DataIC50: 3.40nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702540(US20240360154, Compound Z24-1)
Affinity DataIC50: 3.5nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702643(US20240360154, Compound Z41-1a)
Affinity DataIC50: 3.60nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [C481S](Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702540(US20240360154, Compound Z24-1)
Affinity DataIC50: 3.70nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [C481S](Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702549(US20240360154, Compound Z66-1)
Affinity DataIC50: 3.80nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [C481S](Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702563(US20240360154, Compound Z195)
Affinity DataIC50: 3.90nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702563(US20240360154, Compound Z195)
Affinity DataIC50: 3.90nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [C481S](Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702643(US20240360154, Compound Z41-1a)
Affinity DataIC50: 4.10nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702546(US20240360154, Compound Z24-b)
Affinity DataIC50: 4.20nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702561(US20240360154, Compound Z120)
Affinity DataIC50: 4.30nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702584(US20240360154, Compound Z41-2a)
Affinity DataIC50: 4.30nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702623(US20240360154, Compound Z168)
Affinity DataIC50: 4.5nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [C481S](Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702541(US20240360154, Compound Z24-2)
Affinity DataIC50: 4.70nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [C481S](Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702644(US20240360154, Compound Z41-1b)
Affinity DataIC50: 4.80nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [C481S](Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702557(US20240360154, Compound Z25)
Affinity DataIC50: 4.90nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702526(US20240360154, Compound Z16-2)
Affinity DataIC50: 5nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702541(US20240360154, Compound Z24-2)
Affinity DataIC50: 5nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [C481S](Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702523(US20240360154, Compound Z14)
Affinity DataIC50: 5.10nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [C481S](Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702602(US20240360154, Compound Z141)
Affinity DataIC50: 5.10nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702545(US20240360154, Compound Z24-a)
Affinity DataIC50: 5.5nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702644(US20240360154, Compound Z41-1b)
Affinity DataIC50: 5.5nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [C481S](Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702526(US20240360154, Compound Z16-2)
Affinity DataIC50: 5.60nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702579(US20240360154, Compound Z126)
Affinity DataIC50: 5.70nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702630(US20240360154, Compound Z79)
Affinity DataIC50: 5.80nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [C481S](Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702546(US20240360154, Compound Z24-b)
Affinity DataIC50: 5.80nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702557(US20240360154, Compound Z25)
Affinity DataIC50: 6nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [C481S](Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702585(US20240360154, Compound Z41-2b)
Affinity DataIC50: 6.10nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702568(US20240360154, Compound Z64-1)
Affinity DataIC50: 6.30nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702631(US20240360154, Compound Z177)
Affinity DataIC50: 6.40nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702544(US20240360154, Compound Z64)
Affinity DataIC50: 6.5nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [C481S](Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702558(US20240360154, Compound Z26)
Affinity DataIC50: 6.5nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [C481S](Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702623(US20240360154, Compound Z168)
Affinity DataIC50: 6.60nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702549(US20240360154, Compound Z66-1)
Affinity DataIC50: 6.70nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702596(US20240360154, Compound Z136)
Affinity DataIC50: 6.70nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [C481S](Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702514(US20240360154, Compound Z4-1)
Affinity DataIC50: 6.80nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702558(US20240360154, Compound Z26)
Affinity DataIC50: 7nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [C481S](Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702531(US20240360154, Compound Z22)
Affinity DataIC50: 7.20nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [C481S](Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702560(US20240360154, Compound Z89)
Affinity DataIC50: 7.5nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [C481S](Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702598(US20240360154, Compound Z25-3a)
Affinity DataIC50: 7.60nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [C481S](Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702596(US20240360154, Compound Z136)
Affinity DataIC50: 7.60nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702525(US20240360154, Compound Z16-1)
Affinity DataIC50: 7.60nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Genfleet Therapeutics (Shanghai)

US Patent
LigandPNGBDBM702523(US20240360154, Compound Z14)
Affinity DataIC50: 7.60nMAssay Description:A 3-fold gradient concentration stock solution of 1000× compound was prepared using DMSO and diluted 100-fold to 10× compound stock solution using re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2025
Entry Details
US Patent

Displayed 1 to 50 (of 294 total ) | Next | Last >>
Jump to: